Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases

A Sutnar, M Pesta, V Liska, V Treska, T Skalicky, S Kormunda, O Topolcan, R Cerny, L Jr Holubec

. 2007 ; 28 (5) : 247-252.

Language English Country Switzerland

Grant support
NR7905 MZ0 CEP Register

Digital library NLK
Full text - Část
Source

E-resources

NLK Karger Journals from 1987 to 2009
ProQuest Central from 1997-12-01 to 2015-12-31
Medline Complete (EBSCOhost) from 2005-01-01 to 2016-12-31
Health & Medicine (ProQuest) from 1997-12-01 to 2015-12-31
Public Health Database (ProQuest) from 1997-12-01 to 2015-12-31
ROAD: Directory of Open Access Scholarly Resources from 1987

BACKGROUND: Nowadays we know that survival rates do not differ between repeated and single liver resections for colorectal liver metastases (CLM). To be able to determine patients prone to early recurrence, the use of different markers with a better prognostic value than the routinely employed tumor markers is required. AIM OF STUDY: The aim of our study was to assess mRNA expression of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA in tissue samples from CLM and their relationship to disease-free interval (DFI) and overall survival (OS). PATIENTS AND METHODS: The liver tumor biopsies were obtained from 40 patients suffering from CLM treated with radical surgery. mRNA expression levels of CEA, MMPs and TIMPs and a housekeeping gene (GAPDH) were quantified using RT-PCR. RESULTS: The increased expression of CEA, MMP-9 and TIMP-1 in CLM was associated with a short DFI and a high tendency to early CLM recurrence. Statistical analysis confirmed CEA, MMP-9 and TIMP-1 expression as prognostic factors of survival. CONCLUSION: This study demonstrated the importance of CEA, MMP-9 and TIMP-1 in the prognostication of DFI and OS. Copyright 2007 S. Karger AG, Basel.

000      
03976naa 2200733 a 4500
001      
bmc10013270
003      
CZ-PrNML
005      
20130813153859.0
008      
100602s2007 sz e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Sutnar, Alan $7 xx0081862
245    10
$a Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases / $c A Sutnar, M Pesta, V Liska, V Treska, T Skalicky, S Kormunda, O Topolcan, R Cerny, L Jr Holubec
314    __
$a Department of Surgery, University Hospital Pilsen, Pilsen, Czech Republic
520    9_
$a BACKGROUND: Nowadays we know that survival rates do not differ between repeated and single liver resections for colorectal liver metastases (CLM). To be able to determine patients prone to early recurrence, the use of different markers with a better prognostic value than the routinely employed tumor markers is required. AIM OF STUDY: The aim of our study was to assess mRNA expression of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA in tissue samples from CLM and their relationship to disease-free interval (DFI) and overall survival (OS). PATIENTS AND METHODS: The liver tumor biopsies were obtained from 40 patients suffering from CLM treated with radical surgery. mRNA expression levels of CEA, MMPs and TIMPs and a housekeeping gene (GAPDH) were quantified using RT-PCR. RESULTS: The increased expression of CEA, MMP-9 and TIMP-1 in CLM was associated with a short DFI and a high tendency to early CLM recurrence. Statistical analysis confirmed CEA, MMP-9 and TIMP-1 expression as prognostic factors of survival. CONCLUSION: This study demonstrated the importance of CEA, MMP-9 and TIMP-1 in the prognostication of DFI and OS. Copyright 2007 S. Karger AG, Basel.
650    _2
$a adenokarcinom $x genetika $x chirurgie $x metabolismus $x mortalita $x sekundární $7 D000230
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a karcinoembryonální antigen $x biosyntéza $x genetika $7 D002272
650    _2
$a kolorektální nádory $x genetika $x metabolismus $x mortalita $7 D015179
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nádory jater $x genetika $x metabolismus $x mortalita $x sekundární $7 D008113
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a matrixová metaloproteinasa 7 $x biosyntéza $x genetika $7 D020783
650    _2
$a matrixová metaloproteinasa 9 $x biosyntéza $x genetika $7 D020780
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádorové proteiny $x biosyntéza $x genetika $7 D009363
650    _2
$a prognóza $7 D011379
650    _2
$a messenger RNA $x biosyntéza $7 D012333
650    _2
$a RNA nádorová $x biosyntéza $7 D012334
650    _2
$a analýza přežití $7 D016019
650    _2
$a tkáňový inhibitor metaloproteinasy 1 $x biosyntéza $x genetika $7 D019715
650    _2
$a tkáňový inhibitor metaloproteinasy 2 $x biosyntéza $x genetika $7 D019716
650    _2
$a financování organizované $7 D005381
700    1_
$a Pešta, Martin, $d 1976- $7 xx0073915
700    1_
$a Liška, Václav, $d 1978- $7 xx0073943
700    1_
$a Třeška, Vladislav, $d 1957- $7 jn20000402436
700    1_
$a Skalický, Tomáš, $d 1965- $7 xx0017169
700    1_
$a Kormunda, Stanislav $7 xx0103970
700    1_
$a Topolčan, Ondřej, $d 1943- $7 jn20000402383
700    1_
$a Černý, Radim, $d 1943- $7 jk01021619
700    1_
$a Holubec, Luboš, $d 1972- $7 xx0068645
773    0_
$t Tumour Biology $w MED00008757 $g Roč. 28, č. 5 (2007), s. 247-252
910    __
$a ABA008 $b x $y 7
990    __
$a 20110413111238 $b ABA008
991    __
$a 20130813154407 $b ABA008
999    __
$a ok $b bmc $g 749136 $s 612765
BAS    __
$a 3
BMC    __
$a 2007 $b 28 $c 5 $d 247-252 $m Tumor biology $n Tumor Biol $x MED00008757
GRA    __
$a NR7905 $p MZ0
LZP    __
$a 2010-B2/ipme

Find record